PNC Financial Services Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,007
| Closed | -$11K | – | 4371 |
|
|
2017
Q3 | $11K | Buy |
1,007
+510
| +103% | +$5.57K | ﹤0.01% | 3661 |
|
|
2017
Q2 | $5K | Buy |
497
+164
| +49% | +$1.65K | ﹤0.01% | 3838 |
|
|
2017
Q1 | $3K | Buy |
333
+311
| +1,414% | +$2.8K | ﹤0.01% | 3903 |
|
|
2016
Q4 | $0 | Buy |
+22
| New | – | ﹤0.01% | 4189 |
|
|
2016
Q3 | – | Sell |
-328
| Closed | -$4K | – | 4512 |
|
|
2016
Q2 | $4K | Sell |
328
-57
| -15% | -$695 | ﹤0.01% | 3987 |
|
|
2016
Q1 | $4K | Buy |
385
+13
| +3% | +$135 | ﹤0.01% | 3984 |
|
|
2015
Q4 | $3K | Hold |
372
| – | – | ﹤0.01% | 4091 |
|
|
2015
Q3 | $3K | Sell |
372
-18
| -5% | -$145 | ﹤0.01% | 4212 |
|
|
2015
Q2 | $4K | Buy |
390
+184
| +89% | +$1.89K | ﹤0.01% | 4219 |
|
|
2015
Q1 | $2K | Hold |
206
| – | – | ﹤0.01% | 4373 |
|
|
2014
Q4 | $2K | Buy |
+206
| New | +$2K | ﹤0.01% | 3879 |
|
|
2013
Q4 | – | Sell |
-2,374
| Closed | -$12K | – | 3697 |
|
|
2013
Q3 | $12K | Sell |
2,374
-369
| -13% | -$1.87K | ﹤0.01% | 3201 |
|
|
2013
Q2 | $14K | Buy |
+2,743
| New | +$14K | ﹤0.01% | 2950 |
|